Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations and acronyms used in this report
Abrir esta carpeta y ver su contenidoOpening ceremony
Abrir esta carpeta y ver su contenidoHerbal medicines
Abrir esta carpeta y ver su contenidoKeynote address
Cerrar esta carpetaSafety of blood-derived products
Ver el documentoQuality and safety of plasma for fractionation
Ver el documentoProcedures for inactivation and removal of viruses
Ver el documentoGMP in blood plasma collection centres
Ver el documentoPlasma fractionation - Brazilian programme of self-sufficiency in blood products
Ver el documentoSafety of blood products in New Zealand
Ver el documentoRegulatory experience in Argentina
Ver el documentoSafety of blood products in the Islamic Republic of Iran
Ver el documentoRecommendations
Abrir esta carpeta y ver su contenidoAntimicrobial resistance - new initiatives
Abrir esta carpeta y ver su contenidoHarmonization I
Abrir esta carpeta y ver su contenidoHarmonization II
Abrir esta carpeta y ver su contenidoProtection of trial subjects in clinical trials
Abrir esta carpeta y ver su contenidoRegulating biotechnology products
Abrir esta carpeta y ver su contenidoRegulatory challenges: health sector reform and drug regulatory capacity
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines I
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines II
Abrir esta carpeta y ver su contenidoCounterfeit pharmaceutical products
Abrir esta carpeta y ver su contenidoHomoeopathy
Abrir esta carpeta y ver su contenidoSafety monitoring
Abrir esta carpeta y ver su contenidoE-Commerce
Abrir esta carpeta y ver su contenidoCurrent topics
Abrir esta carpeta y ver su contenidoRegulatory challenges of new technologies
Ver el documentoList of participants
Ver el documentoBack cover
 

Safety of blood products in the Islamic Republic of Iran

Dr A. Kebriaeezadeh, Islamic Republic of Iran

Blood products are regulated by the Iranian Blood Transfusion Organization (IBTO) and the National Regulatory Authority (NRA), both of which belong to the Ministry of Health.

Blood products may be either locally manufactured or imported. All such products need to be registered and approved by the NRA for marketing. An establishment licence issued by the NRA is needed by manufacturers, importers and distributors. The NRA is also responsible for conducting batch release testings. Documentation and other requirements for registration are very similar for locally made and imported product, and include the site master file, drug master file, GMP certificate. A CPP (certificate of a pharmaceutical product) from the country of origin and a list of countries where the product is registered and/or marketed are also required.

In the Islamic Republic of Iran, manufacturers of blood products must have an establishment licence for their production facility. Most importantly, before a marketing authorization for blood products can be granted, a rigorous review of their safety, quality and efficacy by the NRA is essential.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013